Cardiology Online

Home

Welcome

Scientific Committees

Timetable

Program Topics

Program

Opening Lecture

International Academy of Cardiology Awards

IAC Distinguished Fellowship Awards

Photos photos

General Information

Abstract Guidelines

Abstract Form

Instructions for the Preparation of Posters

Registration Form

Accommodation

Exhibition

Contact Us

Click here to download List of Scientific Presentations - Program (pdf)

Click here for Writing Instructions &
Sending your Article(s)
to Monduzzi Editore -
Medimond's Proceeding Book

 

 

Click here to download the Preliminary List of Scientific Presentations as a pdf.

OXIDATIVE STRESS, BIOMARKERS, AND SIGNAL TRANSDUCTION IN CARDIOVASCULAR DISEASE
Oxidative Stress: Biology and Biomarkers in the Vascular System
Kenneth Maiese, Wayne State University School of Medicine, Detroit, MI, USA

The Role of Excess Radical Flux in Heart Disease
Pawan K. Singal, Institute of Cardiovascular Sciences St. Boniface Research Center, Winnipeg, MB, Canada

Signal Transduction Pathways Implicated in the Development of Atherosclerosis
Salomon Amar, Boston University, Boston, MA, USA

Nitric Oxide and Peroxynitrite Imbalance in Heart Failure
Tadeusz Malinski, Ohio University, Athens, OH, USA

Molecular Regulation of Apoptosis in the Heart: "To Be or Not to NF-KB
Lorrie A. Kirshenbaum, University of Manitoba, Winnipeg, MB, Canada

Thromboxane Receptor at the Cross-Road of Inflammation and Oxidative Stress in Atherogenesis
Domenico Pratico, Temple University, Philadelphia, PA, USA

Coronary Arteriosclerosis in Patients with Acute Ischemic Stroke - Prevalence and Characteristics as Measured by CT Angiography, Echocardiography and Biomarkers
Jesper K. Jensen, Odense University Hospital, Denmark

Identification of a Cardiac Specific Protein Transduction Domain by In Vivo Biopanning Using A M13 Phage Peptide Display Library
Maliha Zahid, University of Pittsburgh, PA, USA

OXIDATIVE STRESS AND INFLAMMATION IN CARDIOVASCULAR DISEASE

Pathophysiology of Aortic Stenosis: Role of Oxidative Stress
Donald D. Heistad, University of Iowa College of Medicine, Iowa City, IA, USA

LOX-1 in Cardiovascular Dysfunction
Tatsuya Sawamura, National Cardiovascular Center Research Institute, Suita, Osaka, Japan

LOX-1 and Hypertension
Jawahar L. Mehta, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Regulation of NAD(P)H Oxidase by Hemodynamic Forces: Impact On Arteriosclerosis
Henning Morawietz, Dresden University of Technology, Dresden, Germany

Novel Myleoperoxidase Inhibitors Inhibit LDL Oxidation and Improve Vasodilatation
Kirkwood A. Pritchard Jr., Medical College of Wisconsin, Milwaukee, WI, USA

CRP and Cardiovascular Disease: Use in Clinical Practice?
Borge G. Nordestgaard, Copenhagen University, Denmark

HSP60, Inflammation and Cardiovascular Disease
Anne A. Knowlton, University of California, Davis, CA, USA

THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASES

9P21 - A New Genetic Factor for Coronary Artery Disease
Robert Roberts, University of Ottawa Heart Institute, Ottawa, ON, Canada

Gene Delivery to Modify Ion Channels in Arteries
James D. Marsh, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Genetic Basis of Polygenic Hypertension
Alan Y. Deng, Research Center- CHUM Technopole Angus, Montreal, Canada

Cardiac Hypertrophy and Fibrosis in Npr1 Gene-Disrupted Mice: Role of Blood Pressure-Dependent and -Independent Mechanisms
Kailash N. Pandey, Tulane University School of Medicine, New Orleans, LA, USA

Studies of the Genetic Basis of Congenital Heart Defects
Neil E. Bowles, University of Utah School of Medicine, Salt Lake City, UT, USA

Genetic Epidemiology of Left Ventricular Hypertrophy: Where are we now?
Jonathan N. Bella, Bronx -Lebanon Hospital Center, Bronx, NY, USA

The Role of DNA Damage in Atherosclerosis and Vascular Smooth Muscle Cell Apoptosis
Takafumi Ishida, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan

Myocardin Induction of Microrna-1 Inhibits the Proliferation of Human Vascular Smooth Muscle Cells
Xi-Long Zheng, Libin Cardiovascular Institute of Alberta, Calgary, AL, Canada

PATHOGENESIS OF ATHEROSCLEROSIS

Deducing the Mechanism of Diseases through Experimental Therapy
Mohamad Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Role of Inflammasome in Cardiovascular Diseases
Masafumi Takahashi, Jichi Medical University, Tochigi, Japan

Novel Mechanisms of Macrophage Activation and Cardiometabolic Disorders
Masanori Aikawa, Brigham and Women's Hospital, Boston, MA, USA

Modulation of the Atherosclerotic Plaque by Shear Stress
Stephanie Lehoux, Lady Davis Institute McGill University, Montreal, QC, Canada

Proteomics and Metabolomics: Ready for the Prime Time in Cardiovascular Research
Manuel Mayr, The James Black Centre, London, UK

Is APOB100 Innocent in Atherosclerosis? Identification of an Apob100 Derived Chemotactic Peptide for Human Inflammatory Cells
Zhong-Qun Yan, Karolinska Institute, Stockholm, Sweden

Revisiting the Role of Infections in Coronary Heart Disease
Mohammad Madjid, Texas Heart Institute, Houston, TX, USA

The Role of Plasmacytoid Dendritic Cells in Plaque Destabilization
Alexander Niessner, Medical University of Vienna, Austria

NEW CONCEPTS IN CARDIAC REMODELING

Subcellular Remodeling in Congestive Heart Failure due to Myocardial Infarction
Naranjan S. Dhalla, International Academy of Cardiovascular Sciences, Winnipeg, Manitoba, Canada

Differential Matrix Metalloproteinase Proteomic Profiling in Patients at Risk for Heart Failure: Diagnostic and Prognostic Implications for Personalized Medicine
Francis G. Spinale, Medical University of South Carolina, Charleston, SC, USA

Autophagy in Ischemic Heart Disease
Dipak K. Das, University of Connecticut Medical Center, Farmington, CT, USA

Aging and Modulation of the Renin-Angiotensin-System Post Infarction
Bodh I. Jugdutt, University of Alberta Hospitals, Edmonton, AL, Canada

Endothelial Myocyte Matrix in Cardiac Remodeling
Suresh C. Tyagi, University of Louisville School of Medicine, Louisville, KY, USA

Inhibition of Malonyl COA Decarboxylase Decreases Adverse Cardiac Remodelling Post-Infarction
Gary Lopaschuk, University of Alberta, Edmonton, AL, Canada

The Role of Thrombospondin-1 In Infarct Healing and Cardiac Remodeling
Nikolaos Frangogiannis, Baylor College of Medicine, Houston, TX, USA

Left Ventricular Remodeling in Hypertension and Obesity: Hemodynamic, Metabolic and Neurohormonal Basis
Julio Chirinos, Philadelphia VA Medical Center, PA, USA

Early Insulin Treatment Prevents Post-Ischemic Heart Failure
Feng Gao, Fourth Military Medical University, Xian, China

VULNERABLE PLAQUE IN CORONARY ARTERY DISEASE: NOVEL IMAGING AND BIOMARKERS

Characteristics of Vulnerable Plaques in Multiple-Detector Row CT-Based Coronary Angiography
Yasuki Kihara, Hiroshima University Hospital, Hiroshima, Japan

Myeloperoxidase in Coronary Artery Disease
Janos G. Filep, University of Montreal, Canada

Novel Coronary Imaging and Multi-Biomarker Strategy for Acute Coronary Syndrome
Yoshihiko Seino, Nippon Medical School Chiba-Hokusoh Hospital, Chiba, Japan

Cardiac Troponin and Heart Failure
Wayne L. Miller, Mayo Clinic, Rochester, MN, USA

Mechanism of ACS Onset - Insight from Angioscopy
Yasunori Ueda, Osaka Police Hospital, Osaka, Japan

CORONARY CIRCULATION - FROM PHYSIOLOGY TO CLINICAL PATHOLOGY

What Is Coronary Flow Reserve?
Sanjiv Kaul, Oregon Health & Science University, Portland, OR, USA

Coronary Microembolization- Bedside to Bench and Back to Bedside
Gerd Heusch, University of Essen Medical School, Essen, Germany

Myocardial Ischemia beyond Atherosclerotic Plaque
Francesco Fedele, Universita' Degli Studi Di Roma "La Sapienza", Rome, Italy

Regulation of Coronary Microcirculation by Adenosine: From Physiology to Pathophysiology
Lih Kuo, Texas A&M Health Science Center, Temple, TX, USA

Vasomotor Symptoms and Coronary Artery Calcium
Matthew A. Allison, University of California, San Diego, La Jolla, CA, USA

THE EXPERIMENTAL THERAPY OF ACUTE MYOCARDIAL SYNDROMES

Acute Myocardial Infarction: Past, Present and Future
Mervyn S. Gotsman, Hadassah University Hospital, Jerusalem, Israel

Clinical Application of Genetic and Molecular Medicine in Acute Coronary Syndrome
Lewis C. Becker, Johns Hopkins University School of Medicine, Baltimore, MA, USA

Alginates for the Treatment of Acute Myocardial Infarction and Heart Failure
Hani N. Sabbah, Henry Ford Hospital, Detroit, MI, USA

Cardioprotective Action of Oxytocin: Possible Role in Stress
Daniela Jezova, Slovak Academy of Sciences, Bratislava, Slovakia

Hydrogen Sulfide, a Gaseous Biological Mediator with Cardioprotective Effects: The Results of Preclinical and Early-Stage Clinical Studies
Csaba Szabo, Ikaria Inc., Seattle, WA, USA

Remote Ischemic Conditioning and Its Clinical Application
Igor E. Konstantinov, Royal Children's Hospital, Parkville, Australia

ARTERIAL DISEASE AND HYPERTENSION

Peripheral Arterial Disease
Wilbert S. Aronow, New York Medical College, Valhalla, NY, USA

Left Ventricular Hypertrophy in Hypertension – Molecular and Cellular Mechanisms
Clive Rosendorff,
Mt. Sinai School of Medicine and the J.J. Peters VA Medical Center, Bronx, NY, USA

Angiotensin-Independent Effects Mediated via the (Pro)Renin Receptor
Alexander H.J. Danser, Erasmus Medical Center, Rotterdam, The Netherlands

ACE2 in Cardio-Pulmonary Disease
Mohan K. Raizada, University of Florida, Gainesville, FL, USA

Carotid Artery Stenting - The Dilemma of Ethically Questionable Trials
Harald Mudra, Krankenhaus Munchen Neuperlach, Munich, Germany

Pulmonary Pressure Response to Exercise: From Physiology to Pathology
Eduardo Bossone, Cava de Tirreni & Amalfi Coast Hospital, Amalfi Coast, Italy

Neural Mechanisms of Hypertension: From the View of the Central Nervous System
Yoshitaka Hirooka, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Chronic Thrombo-Embolic Pulmonary Hypertension: Evaluation and Treatment
Ori Ben-Yehuda, University of California, San Diego, CA, USA

Endothelial Progenitor Cells: Role in Vascular Biology and Implications of the Renin-Angiotensin System
Sven Wassmann, Lady Davis Institute and Jewish General Hospital, Montreal, Canada

Prehypertension and Aortic Stiffness
Turgay Celik, Gulhane School of Medicine, Ankara, Turkey

Infrapopliteal Intervention for Limb Salvage
Osami Kawarada, Stanford University Medical Center, Stanford, CA, USA

UPDATE / RECENT ADVANCES IN ECHOCARDIOGRAPHY

Echocardiographic Evaluation of LV Diastolic Function
Sherif F. Nagueh, Baylor College of Medicine, Houston, TX, USA

Real Time 3-Dimensional Transesophageal Echocardiography
Navin C. Nanda, University of Alabama at Birmingham, AL, USA

3D Echocardiography in Clinical Practice
Smadar Kort, Stony Brook University Medical Center Health Sciences Center, Stony Brook, NY, USA

Clinical Application of 3D Echocardiography
Takahiro Shiota, The Cleveland Clinic Foundation, Cleveland, OH, USA

UPDATE / RECENT ADVNACES IN NON-INVASIVE IMAGING / RISK PREDICTION

Vascular Imagings for Evaluation of Cardiovascular Event Risk and Guidance of Treatment
Takanobu Tomaru, Toho University, Sakura City, Japan

Prognostic Significance of Findings from Cardiac Magnetic Resonance
Rungroj Krittayaphong, Mahidol University, Bangkok, Thailand

Magnetic Resonance Spectroscopy: A New Clinical Tool
Gerald Pohost, University of Southern California, Los Angeles, CA, USA

Reciprocal Association between Ectopic Cardiovascular Calcification and Osteoporosis
Elena Aikawa, Brigham and Women's, Boston, MA, USA

Labeling Cardiovascular Stem Cell for Non-Invasive Imaging for Enhanced Engraftment and Efficacy
Dara L. Kraitchman, Johns Hopkins University, Baltimore, MA, USA

Non-Invasive Imaging of Coronary Artery Disease in Obese Patients
Abdou Elhendy, Marshfield, WI, USA

Advances in MR Imaging of Atherosclerosis
Sanjay Rajagopalan, Ohio State University, Athens, OH, USA

EMERGING CONCEPTS IN ACUTE CORONARY SYNDROMES

CPR: When Dead Is Only Mostly Dead
Bruce D. Adams, William Beaumont Army Medical Center, El Paso, TX, USA

Cardio Cerebral Resuscitation for Witness Cardiac Arrest Victims
Mohammad-Reza Movahed, University of Arizona Sarver Heart Center, Tucson, AR, USA

Acute Myocardial Infarction in Chile before and after the Chilean Health Reform
Rienzi A. Diaz, University of Valparaiso, Chile

The Success of Regionalized Stemi Receiving Center Networks
Ivan C. Rokos, Geffen School of Medicine at UCLA, Los Angeles, CA, USA

NEW DIRECTIONS IN THE TREATMENT OF ISCHEMIC HEART DISEASE / INTERVENTIONAL CARDIOLOGY

Management of Stable Angina Update 2010: What is New and What still Works?
Udho Thadani, University of Oklahoma, Oklahoma City, OK, USA

PCI in Patients with Reduced Left Ventricular Function: An Under Recognized Manageable Issue
George W. Vetrovec, Virginia Commonwealth University, Richmond, VA, USA

The Treatment of Unprotected Left Main Coronary Disease
Barry F. Uretsky, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Serum Srage, a Predictor of Restenosis Following Percutaneous Coronary Intervention
Kailash Prasad, University of Saskatchewan, Saskatoon, Canada

Tips, Tricks and Pitfalls in Acute Percutaneous Coronary Interventions
Deepak Jain, Medizinische Klinik II  Universitatskinikum, Lubeck, Germany

Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography
Kenji Okumura, Nagoya University School of Medicine, Nagoya, Japan

Tailoring Post Stent Antiplatelet Treatment to Individual Patient
Hanumanth K. Reddy, Medical Center of South Arkansas, El Dorado, AR, USA

Clopidogrel-PPI Interaction: Where Do We Stand
Subhash Banerjee, VA North Texas & University of Texas Southwestern Medical Center, Dallas, TX, USA

CARDIOVASCULAR EPIDEMIOLOGY

Increasing Life Expectancy in the Western World and the Role of Cardiovascular Prevention
Ulrich Keil, University of Muenster, Germany

An Update on Cardiovascular Disease Risk Prediction from the Multi-Ethnic Study of Atherosclerosis
Michael H. Criqui, University of California, San Diego, La Jolla, CA, USA

The Epidemiology of Valvular Heart Diseases. The Problem Is Growing
Phyllis Supino, State University of New York (SUNY), NY, USA

Cardiovascular Disease in the Asians - Pharmacogenetic Differences
Gordon L. Fung, UCSF Medical Center at Mt. Zion, San Francisco, CA, USA

Gender Differences in Exercise Testing In a Cardiology Practice
Yzhar Charuzi, UCLA School of Medicine, Los Angeles, CA, USA

Prenatal Exposure to Maternal Undernutrition Induces Cardiac Dysfunction in Post Natal Life
Paramjit S. Tappia, University of Manitoba, Winnipeg, MN, Canada

LIFESTYLE FACTORS AND CVD

Wine, Beer, and Cardiovascular Conditions: Scientific Truths in a New Decade
Arthur Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA

Trials of Dietary Supplements in the Prevention of Cardiovascular Disease: Lessons Learned, Future Promise
Howard D. Sesso, Brigham & Women's Hospital, Boston, MA, USA

Current Issues in Primary Prevention of Acute Coronary Syndromes; The Role of Diet and Exercise
Christos Pitsavos, University of Athens, Greece

Control of Risk Factors for CAD without Medications: Role of Lifestyle Changes
Mario F. Maranhao, Curitiba, Brazil

How Much of Cardiovascular Disease Risk can be Attribute to Diet
Demosthenes B. Panagiotakos, Harokopio University, Athens, Greece

NOVEL RISK FACTORS

Novel Risk Factors for Cardiovascular Disease
Elizabeth L. Barrett-Connor, University of California, San Diego, La Jolla, CA, USA

Novel Risk Factors: Fact or Fiction?
Philip R. Liebson, Rush University Medical, Chicago, IL, USA

Obesity and Myocardial Repolarization
Martin A. Alpert, St. John's Mercy Medical Center, St Louis, MO, USA

Vitamin D and Cardiovascular Disease
Vera Bittner, University of Alabama at Birmingham, AL, USA

The Ratio of Serum Adiponectin Level to Homeostasis Model Assessment of Insulin Resistance is a Powerful Index of Metabolic Syndrome in an Aged Japanese Population: Results from The King Study
Mitsuhiro Yokota, Aichi-Gakuin University, Nagoya, Japan

Cognitive Functioning in Patients with Severe Cardiac Disease
Luciano Daliento, University of Padua, Italy

Testosterone and Cardiovascular Disease: A Sex-Specific Connection
Gail Laughlin, University of California, San Diego, La Jolla, CA, USA

Heart Rate - What Role In Cv Risk And Protection?
Sandeep Gupta, Whipps Cross and St. Bartholomew's Hospitals, Leytonstone, UK

LIPIDS, LIPOPROTEINS AND CVD

Antiretrovirals and Cardiovascular Disease
Changi Johnny Chen, Baylor College of Medicine, Houston, TX, USA

Is there Evidence for Therapeutic Goals Beyond LDL-C?
Jennifer G. Robinson, University of Iowa, Iowa City, IA, USA

Carbamylated LDL - Missing Link between Uremia and Atherosclerosis Insights into the Mechanisms of Atrial Fibrillation
Alexei G. Basnakian, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Is Low HDL a Marker or a Causal Factor for Heart Disease?
Anne Tybjærg-Hansen, Copenhagen University Hospital, Denmark

Efficacy and Safety of Long-Term Rosuvastatin Treatment in High Cardiovascular Risk Patients
Shorena Chumburidze, National Center of Therapy, Tibilsi, Georgia   

INSIGHTS INTO THE MECHANISM OF ATRIAL FIBRILLATION

Mechanisms of Atrial Fibrillation
Peter H. Backx, University of Toronto, ON, Canada

Atrial Structural and Functional Remodeling: Impact on Atrial Fibrillation Development
Teresa S. Tsang, Mayo Clinic, Rochester, MN, USA

Calcium/Calmodulin Kinase, Dysfunctional Sarcoplasmic Reticulum, and Atrial Fibrillation
Dobromir Dobrev, Dresden University of Technology, Dresden, Germany 

Cardiac Consequences of Altered Signal Transduction in Atrial Fibrillation
Andreas Goette, St. Vincenz-Hospital, Paderborn, Germany

MRI for AF Management: Staging AF And Beyond
Nasir Marrouche, University of Utah Health Sciences Center, Salt Lake City, UT, USA

The Association of Left Atrial Abnormality and Myocardial Ischemia
Vignendra Ariyarajah, Bergen Cardiac Care Centre, Winnipeg, MB, Canada

STROKE PREVENTION AND MANAGEMENT OF ATRIAL FIBRILLATION

Left Atrial Appendage Occlusion
Horst Sievert, Cardiovascular Center Frankfurt, Germany

Stroke Prevention in AF Patients: Multiple Therapeutic Goals
Alessandro Capucci, Università Politecnica delle Marche, Torrette, Italy

New Developments in Anticoagulation in Atrial Fibrillation
Antonio Martinez-Rubio, Hospital de Sabadell, Barcelona, Spain

Telemedicine for Diagnosing and Managing Paroxysmal Atrial Fibrillation in Outpatients. The Phone, Not the Pill, In the Pocket
Arie Roth, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel

ADVANCES IN THE NONPHARMACOLOGIC MANAGEMENT OF ATRIAL FIBRILLATION AND SUPRAVENTRICULAR TACHYCARDIA

The Emerging Use of Cryoablation for the Treatment of Atrial Fibrillation
Peter G. Guerra, Montreal Heart Institute, Canada

Minimally Invasive Surgery for Atrial Fibrillation: Outcomes and Results
Mark A. Wood, Virginia Commonwealth University Medical Center, Richmond, VA, USA

Remote Catheter Navigation in Electrophysiologic Procedures: Clinical Applications and New Concepts
Eli S. Gang, Cardiovascular Medical Group of So. California, Beverly Hills, CA, USA

Catheter Ablation of Chronic Atrial Fibrillation Guided by the Atrial Electrogram
Shih-Ann Chen, Veterans General Hospital, Taipei, Taiwan, ROC

Ablation of Atrial Fibrillation Using a Novel Uni- and Bipolar Radiofrequency Energy Ablation System
Thomas Deneke, University of Bochum, Germany

Non Fluoroscopic RF Ablation of AV Nodal Tachycardia and Cavo-Tricuspid Itsmus
Luis Tercedor Sánchez, University Hospital Virgen de las Nieves, Granada, Spain

SUDDEN CARDIAC DEATH

Voodoo Death: The Modern Lessons of Neurocardiology
Martin A. Samuels, Brigham and Women's Hospital. Boston, MA, USA

Genetic Susceptibility to Sudden Cardiac Death
Sumeet S. Chugh, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Diagnosis of ARVC, Modification of the Task Force Criteria
Frank I. Marcus, Sarver Heart Center, Tucson, AZ, USA

Risk Stratification for Sudden Cardiac Death: Insights from Clinical Trials
Michael E. Cain, University at Buffalo School of Medicine & Biomedical Sciences, Buffalo, NY, USA

Fluctuations of ECG and Risk Stratification in Brugada Syndrome
Masahiko Takagi, Osaka City University Graduate School of Medicine, Osaka, Japan

Isolated Ventricular Noncompaction: Risk Factors and Indications for ICD Therapy
Firat Duru, University Hospital of Zurich, Switzerland

ADVANCES IN IMPLANTABLE RHYTHM DEVICE THERAPY

The Latest in Implantable Cardioverter Defibrillator Therapy
Sana M. Al-Khatib, Duke Clinical Research Institute, Durham, NC, USA

The Importance of Reducing ICD Shocks
Avi Fischer, Mount Sinai Medical Center, New York, NY, USA

Role of Biventricular Pacing In Patients with Standard Pacing Indications
Jeffrey W. H. Fung, Prince of Wales Hospital, Hong Kong, China

Performance Improvement for Implantable Device Therapy in the Outpatient Setting: Findings from Improve HF
Anne B. Curtis, University of South Florida, Tampa, FL, USA

Myths, Magical Thinking, and MRI: Scanning Implantable Rhythm Device Patients
J. Rod Gimbel, Knoxville, TX, USA

VALVULAR HEART DISEASE

Mitral Balloon Valvuloplasty 19 Year Follow-Up Result and Its Effect on Extreme Pulmonary Hypertension ANS Left Ventricular Function in Patient with Severe Mitral Stenosis
Mohamed Eid Fawzy, University in Cairo, Egypt

Epidemiology of Calcific Aortic Valve Disease
Kevin D. O'Brien, University of Washington, Seattle, WA, USA

Designing Clinical Trials in Valvular Heart Disease: From Bench to Bedside
Nalini M. Rajamannan, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Advances in Heart Valve Surgery: Transcatheter Transcardiac Approaches
Jian Ye, Columbia St. Paul's Hospital, Vancouver, BC, USA

The Effect of Time on Risk Stratification in Infective Endocarditis
Leonard Kritharides, Concord Hospital University of Sydney, Concord, Australia

Valvular Heart Disease; Echocardiography vs Cardiac MRI
Robert W.W. Biederman, Allegheny General Hospital, Pittsburgh, PA, USA

ADVANCES IN THE TREATMENT OF ANEURYSM / THORACIC AORTIC PATHOLOGY

Assessment of Vascular Function in Paediatric Cardiology: An Important Emerging Clinical Area
George Sandor, University of British Columbia, Vancouver, BC, Canada

Cardiovascular Disease in Women with Turner Syndrome
Angela T. Yetman, Primary Children's Medical Center, Salt Lake City, UT, USA

Chest Pain of Aortic Origin: Looking Outside the Box
Harisios Boudoulas, Center for Clinical Research Academy of Athens, Greece

Concurrent Brain Aneurysms in Patients with Thoracic Aortic Aneurysms
John Elefteriades, Yale University School of Medicine, New Haven, CT, USA

Recent Advances in the Treatment of Abdominal Aortic Aneurysm: Role of Phototherapy
S. David Gertz, The Hebrew University--Hadassah Medical School, Jerusalem, Israel

Update on Mechanisms, Markers and Non-Surgical Therapies for Aortic Aneurysm
Jonathan Golledge, James Cook University, School of Medicine, Queensland, Australia

Mast Cell Proteases Contribute to Abdominal Aortic Aneurysm Formation in Mice
Guo-Ping Shi, Brigham and Women's Hospital, Boston, MA, USA

Revisiting Arch Surgery in the Era of Thoracic Stent-Grafting
Francois Dagenais, Laval Hospital, Quebec, Canada

A New Concept of Stent: The Multilayer Stent First Human Study in Peripheral Aneurysm
Michel Henry, Cabinet de Cardiologie, Nancy Cedex, France

WHAT'S NEW IN CARDIOMYOPATHIES

Peripartum Cardiomyopathy: An Update
Uri Elkayam, University of Southern California, Los Angeles, CA, USA

Is Doxorubicin-Induced Cardiomyopathy a Dystrophinopathy?
Marcos A. Rossi, University of Sao Paulo, Ribeirao Preto, Brazil

Pathogenesis of Parvo B19 Induced Inflammatory Cardiomyopathy
Heinz-Peter Schultheiss, Charite-University Medicine Berlin, Germany

Leads from Medicinal Plants to Treat Diabetic Cardiomyopathy
Ramesh K. Goyal, The Maharaja Sayajirao University of Baroda, Gujarat, India

A Preferred Time for Onset of Tako-Tsubo Cardiomyopathy?
Roberto Manfredini, Hospital of Delta, Lagosanto, and University of Ferrara, Italy

Myocardial Ischemia in Hypertrophic Cardiomyopathy
Jamshid Shirani, Geisinger Medical, Danville, PA, USA

Pathogenesis, Diagnostics, Prognosis and Immunomodulatory Treatment of Myocarditis and Inflammatory Cardiomyopathy
Michel Noutsias, University Hospital of Marburg, Germany

Diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy in the Young
Shubhayan Sanatani, University of British Columbia, Vancouver, BC, USA

Arrhythmogenic Right Ventricular Dysplasia: More Common than Previous Thought
Spyridon N. Koulouris, Evangelismos Hospital, Athens, Greece

NOVEL TREATMENT AVENUES IN HEART FAILURE

Nitric Oxide Enhancement in Heart Failure: A Novel Therapeutic Strategy
Anne L. Taylor, Columbia University, New York, NY, USA

New Therapies for Pulmonary Arterial Hypertension
Robert C. Bourge, University of Alabama at Birmingham, AL, USA

Impact of Heart Rate Reduction on Outcome in CAD and Heart Failure
Jeffrey S. Borer, SUNY Downstate, NY, USA

Relaxin in Acute Decompensated Heart Failure
Robert E. Hobbs, Cleveland Clinic, Cleveland, OH, USA

The Role of Coenzyme Q10 in Refractory Congestive Heart Failure
Adarsh Kumar, Govt. Medical College/G.N.D. Hospital, Amritsar, India

Role of Ryanodine Receptor as a New Therapeutic Target in Diabetic Heart Dysfunction
Belma Turan, Ankara University Faculty of Medicine, Ankara, Turkey

Treating Congestion in Advanced Heart Failure
John N. Nanas, University of Athens, Greece

Small Molecule Targeting Of G-Protein Signaling in Heart Failure
Burns C. Blaxall, University of Rochester Medical Center, Rochester, NY, USA

Regulation of PDE5 Expression in the Failing Heart
Yingjie Chen, University of Minnesota, Minneapolis, MN, USA

Controversial Diagnostic and Therapeutic Issues in Pericardial Diseases
Massimo Imazio, Maria Vittoria Hospital, Torino, Italy

HOW TO TREAT HEART FAILURE WHEN PILLS DON'T WORK ANYMORE / CARDIAC SURGERY / MECHANICAL CIRCULATORY SUPPORT

Is Detection of Hibernating Myocardium Necessary For Revascularization In Systolic Heart Failure?
Kanu Chatterjee, University of Iowa, Iowa City, IA, USA

Centrally Mediated Regulation Of Sympathetic Outflow In Heart Failure:  Improving No Brakes With Exercise Training?
Kaushik P. Patel, University of Nebraska Medical Center, Omaha, NE, USA

Current Status of Endoscopic Saphenectomy for CABG
Louis P. Perrault, Montreal Heart Institute, Montreal, Canada

Trends in Heart Transplantation in the United States - 1999 to 2008
Maryl R Johnson, University of Wisconsin Medical School, Madison, WI, USA

The NHLBI's Pediatric Circulatory Support Program: Progress and Future Plans
Brian W. Duncan, Cleveland Clinic, Cleveland, OH, USA

Permanent Ventricular Assist Devices in the Elderly 
Roland Hetzer, German Heart Institute, Berlin, Germany

Current Status of Destination Therapy in the Management of End-Stage Heart Failure
Dan M. Meyer, University of Texas, Dallas, TX, USA

Interventional Heart Failure Therapy In 2010
Ernst R.V. Schwarz, Cedars-Sinai Heart Institute, Los Angeles, CA, USA

Mechanical Circulatory Support Devices: Update 2010
Salpy V. Pamboukian, University of Alabama at Birmingham, AL, USA

Pacing in Heart Failure: When to Pace, When not to?
Juan M. Aranda, Jr, University of Florida, Gainesville, FL, USA

Ultrafiltration Therapy for Heart Failure: An Update for 2010
Amir Kazory, University of Florida, Gainesville, FL, USA

 


C
lick here to download the Preliminary List of Scientific Presentations as a
pdf.